Pharmacist, Ph.D. professor at the Federal University of Juiz de Fora (UFJF), Juiz de Fora-MG, Brazil (2019). PROADI - SUS technical consultant for the process of implementation of pharmaceutical care in Brazilian municipalities, 2019. BSc. (2010) at Federal University of Juiz de Fora, scientific initiation scholarship holder, which has contemplated researches related to pharmaceutical services and drug utilization study. Specialist in public health and clinical pharmacy (2013) by the Holistic Health Care Program - Medical School of Ribeirão Preto, University of São Paulo (Multidisciplinary Residency), Integrative care totaling 6 thousand hour of specialization, worked on Primary (60%), Secondary (20%), Tertiary (20%) care. FAPESP scholarship for the master degree,, Pharmaceutical Sciences - Pharmacoeconomics and clinical pharmacy (2016) from Faculty of Pharmaceutical Sciences of Ribeirão Preto / University of São Paulo (FCFRP / USP), research about Pharmacoeconomics and Clinical Pharmacy. P.hD. Graduate Pharmaceutical Sciences program of the Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (FCFRP / USP), in 2019. The thesis is related to health economics area - pharmacoeconomics with further study pharmacoeconomic analysis for Health Technology Assessment and clinical pharmacy area. This research is about development and validation of a pharmacoeconomic tool. Along this research has been able to development systematic review, clinical trials, epidemiological and validation studies and also techinics about modeling applications and sensitivities analysis for Health Technology Assessment (HTA), in highlight Pharmaceutical Care. Sandwich University of Glasgow, at the Health Economics Health Technology Assessment (HEHTA), under the supervision of Professor Olivia Wu, scholarship BEPE / FAPESP, where was able developed skills in five pharmacoeconomics sub-areas (modeling; health technology assessment in global context, survival analysis, data analysis for health economics, applicability of pharmacoeconomic studies and MCDA analyzes). (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Systemic arterial hypertension (SAH) is a risk factor for 9.4 million deaths worldwide. In Brazil, HAS assigned an annual cost of about 1.5 billion to the Public Health System (PHS). The Pharmaceutical Care (PC) is able to avoid complications of hypertension and reduce health costs. The PC economic analysis in long-term showed that the net return on investment in this pharmaceutical pract…
Non-communicable chronic diseases account for the highest rates of morbidity and mortality in Brazil and the biggest expenditure on outpatient and hospital care. According to the World Health Organization, Systemic Arterial Hypertension (SAH) is a risk factor for 9.4 million deaths worldwide. Some studies have demonstrated the effectiveness of pharmacotherapeutic follow up services in the…
Introduction: The Health Economics and Health Technology Assessment center, supervised by Professor Olivia Wu, with interest in health technology assessment methodologies focuses on the areas of evidence synthesis with excellence in modeling, and systematic review applied to pharmacoeconomics. Objective: This sandwich project aims to improve the modeling and the application of data from a…
| 2 / 2 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 3 / 3 | All Scholarships |
| Associated processes | |
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
| Publications | 6 |
| Citations | 2 |
| Cit./Article | 0.3 |
| Data from Web of Science | |
CAZARIM, MAURILIO DE SOUZA; COELHO DA CRUZ-CAZARIM, ESTAEL LUZIA; BALDONI, ANDRE DE OLIVEIRA; ENES DOS SANTOS, THAIS BUENO; DE SOUZA, PAULA GONCALVES; SILVA, INGRID DE ALMEIDA; REIS RODRIGUES, ROBERTA NIRIAM; FRANCO CORREA MAIA, ALDA CRISTINA; LEIRA PEREIRA, LEONARDO REGIS; SANCHES, CRISTINA. Cost-effectiveness analysis of different dipeptidyl-peptidase 4 inhibitor drugs for treatment of type 2 diabetes mellitus. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, v. 11, n. 2, SI, p. S859-S865, DEC 2017. Web of Science Citations: 2. (14/02087-9)
JOÃO PAULO VILELA RODRIGUES; MAURÍLIO DE SOUZA CAZARIM; SILVANA GAMA FLORENCIO CHACHÁ; ANA DE LOURDES CANDOLO MARTINELLI; LEONARDO RÉGIS LEIRA PEREIRA. Cost-effectiveness analysis is a mandatory strategy for health systems: evidence from a study involving therapies for hepatitis C. Cadernos de Saúde Pública, v. 36, n. 2, p. -, 2020. Web of Science Citations: 0. (16/03584-1, 17/21240-0)
CAZARIM, MAURILIO DE SOUZA; LEIRA PEREIRA, LEONARDO REGIS. Cost-effectiveness analysis of pharmaceutical care for hypertensive patients from the perspective of the public health system in Brazil. PLoS One, v. 13, n. 3, MAR 6 2018. Web of Science Citations: 0. (14/02087-9)
CRUZ-CAZARIM, ESTAEL L. C.; CAZARIM, MAURILIO S.; OGUNJIMI, ABAYOMI T.; PETRILLI, RAQUEL; ROCHA, EDUARDO M.; LOPEZ, V, RENATA F.. Prospective insulin-based ophthalmic delivery systems for the treatment of dry eye syndrome and corneal injuries. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, v. 140, p. 1-10, JUL 2019. Web of Science Citations: 0. (16/03584-1, 14/22451-7)
MAURILIO DE SOUZA CAZARIM; JOÃO PAULO VILELA RODRIGUES; PRISCILA SANTOS CALCINI; THOMAS R. EINARSON; LEONARDO RÉGIS LEIRA PEREIRA. Cost-benefit analysis of pharmacist interventions over 36 months in a university hospital. Revista de Saúde Pública, v. 54, p. -, 2020. Web of Science Citations: 0. (16/03584-1, 17/21240-0)
CAZARIM, MAURILIO DE SOUZA; DOS REIS, TIAGO MARQUES; COELHO DA CRUZ-CAZARIM, ESTAEL LUZIA; LEIRA PEREIRA, LEONARDO REGIS. Systematic review protocol: following PRISMA guide from Cochrane to generate evidence as treatment effect of pharmaceutical care for hypertension in primary care. Brazilian Journal of Pharmaceutical Sciences, v. 56, 2020. Web of Science Citations: 0. (16/03584-1, 17/21240-0)
(References retrieved automatically from State of São Paulo Research Institutions)
CAZARIM, Maurilio de Souza. Avaliação econômica em longo prazo da atenção farmacêutica para pacientes com hipertensão arterial sistêmica. Dissertação (Mestrado) - Faculdade de Ciências Farmacêuticas de Ribeirão Preto. Universidade de São Paulo (USP). Ribeirão Preto. (14/02087-9)
CAZARIM, Maurilio de Souza. Desenvolvimento e validação de uma ferramenta farmacoeconômica para tomada de decisão na implantação do cuidado farmacêutico para pacientes hipertensos no sistema de saúde público. Tese (Doutorado) - Faculdade de Ciências Farmacêuticas de Ribeirão Preto. Universidade de São Paulo (USP). Ribeirão Preto. (16/03584-1)
CV Lattes
ORCID